Jana L Portnow
City of Hope Medical Center · City of Hope Comprehensive Cancer Center LAO
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jana L Portnow as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:15 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07791264 · FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With GlioblastomaCity of Hope Medical Center · not yet recruiting · Glioblastoma, Malignant Glioma, Recurrent Glioblastoma · principal investigator
- Ph1NCT05773664 · Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with GlioblastomaCity of Hope Medical Center · withdrawn · Glioblastoma, Malignant Glioma · principal investigator
- Ph1/Ph2NCT05432804 · Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentNational Cancer Institute (NCI) · recruiting · Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma · principal investigator
- Ph2NCT05139043 · Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain TumorsCity of Hope Medical Center · unknown · Malignant Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain, Recurrent Malignant Brain Neoplasm · principal investigator
- Ph1NCT05139056 · Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade GliomasCity of Hope Medical Center · recruiting · Currently Only Enrolling Glioblastoma Patients at First Recurrence · principal investigator
- Ph1NCT03696030 · HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal MetastasesCity of Hope Medical Center · active not recruiting · Malignant Neoplasm, Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Neoplasm in the Leptomeninges · principal investigator
- Ph1NCT02192359 · Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasCity of Hope Medical Center · active not recruiting · Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of VulnerabilityU19CA264512 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2021 to 2026 · $680,856 awarded in 2026Grant number is on one of their registry trials
- A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade GliomasR01CA198076 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2015 to 2019 · $505,496 awarded in 2019Grant number is on one of their registry trials
- Phase 1 Study of Neural Stem Cells & 5-FC/Leucovorin for the Treatment of Recurrent High Grade GliomasR01FD004816 · FDA · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2014 to 2016 · $195,322 awarded in 2016Same name and institution; not confirmed by an ID
- A Pilot Study of 5-FC and Genetically-Modified Neural Stem Cells to Treat GliomasR21CA137639 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2009 to 2010 · $365,200 awarded in 2010Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2008 to 2026
- Phase 1 and 2 Molecular and Clinical Pharmacodynamic Trials ETCTNUM1CA186717 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI A. Dimitrios Colevas, Alexey V. Danilov, PRIMO N. LARA, HEINZ JOSEF LENZ · fiscal years 2014 to 2026Named on NCT05432804
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.